ArticleJournal of experimental orthopaedics2026
Autologous minced cartilage implantation for treatment of focal cartilage defects of the glenohumeral joint results in good clinical and radiological outcomes after a minimum 2-year follow-up.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Autologous minced cartilage implantation (MCI) has been proposed as a promising single-step procedure for treatment of focal cartilage defects in the knee joint. However, clinical evidence regarding the glenohumeral joint is limited. The purpose of the present study was to evaluate clinical and radiological outcomes after MCI for focal cartilage defects of the glenohumeral joint. Methods: Patients who underwent arthroscopic MCI for focal, grade IV cartilage defects of the glenohumeral joint between October 2021 and March 2023 were analysed. Postoperative clinical evaluation included the Constant-Murley (CM), American Shoulder and Elbow Surgeons (ASES) and Disability of the Arm, Shoulder and Hand (DASH) score, the Simple Shoulder Value (SSV) and assessment of range of motion (ROM) and strength. Postoperative shoulder-dependent athletic ability was evaluated using the Athletic Shoulder Outcome Scoring System (ASOSS). Cartilage repair tissue morphology was assessed on magnetic resonance imaging using the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) 2.0 score. Results: All eight eligible patients (median age at surgery, 25.5 ± 5.5 years) were included in the study, with a median follow-up of 2.5 years (range, 2.0-2.8 years). The focal cartilage defect was located at the glenoid concavity in six patients and humeral head in two patients, with a median size of 2.4 cm Conclusion: MCI for treatment of focal cartilage defects of the glenohumeral joint showed a radiologically successful defect coverage along with good to excellent clinical outcomes in patients with or without concomitant procedures at a minimum 2-year follow-up. Level of Evidence: Level IV, retrospective case series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.